期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 被引量:2
1
作者 Gabriele Stocco Marco Pelin +6 位作者 Raffaella Franca Sara De Iudicibus Eva Cuzzoni Diego Favretto Stefano Martelossi Alessandro Ventura Giuliana Decorti 《World Journal of Gastroenterology》 SCIE CAS 2014年第13期3534-3541,共8页
Azathioprine is a purine antimetabolite drug commonly used to treat inflammatory bowel disease(IBD).In vivo it is active after reaction with reduced glutathione(GSH)and conversion to mercaptopurine.Although this react... Azathioprine is a purine antimetabolite drug commonly used to treat inflammatory bowel disease(IBD).In vivo it is active after reaction with reduced glutathione(GSH)and conversion to mercaptopurine.Although this reaction may occur spontaneously,the presence of isoforms M and A of the enzyme glutathione-S-transferase(GST)may increase its speed.Indeed,in pediatric patients with IBD,deletion of GST-M1,which determines reduced enzymatic activity,was recently associated with reduced sensitivity to azathioprine and reduced production of azathioprine active metabolites.In addition to increase the activation of azathioprine to mercaptopurine,GSTs may contribute to azathioprine effects even by modulating GSH consumption,oxidative stress and apoptosis.Therefore,genetic polymorphisms in genes for GSTs may be useful to predict response to azathioprine even if more in vitro and clinical validation studies are needed.reserved. 展开更多
关键词 INFLAMMATORY BOWEL DISEASE AZATHIOPRINE pharmacoge
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部